1/14
Why can't you use direct oral anticoagulants (DOACs) in patients with mechanical valves (MVs)?
DOACs have been one of the most important advances in my career. And yet, the presence of a MV is one of the few contraindications.
The reason highlights the unique nature of thrombus formation in those with a MV and provides insights into the evolution of human hemostasis.
CAN'T ATTEND IN PERSON? REGISTER VIRTUALLY https://t.co/cDgKDswPqD
Experience the 5th Annual Naples Cardiovascular Summit from anywhere in the world, featuring leading cardiology experts from @NCHRooneyHeart & @MayoClinic. Ideal for primary care, nurses, cardiologists & trainees
📊 Research Summary: Adults with #AFib who drank at least one cup of caffeinated coffee daily after successful cardioversion had a lower risk of recurrence than those who abstained from coffee and caffeine.
#AHA25
https://t.co/CoGRhvpUbZ
Pseudo-Mobitz type II block ❗
Everything depends on the timing when the junctional escape fires and the sinus rate.
Quote: "Thus, when all the PR intervals remain constant, Mobitz type II block maybe diagnosed erroneously if sinus slowing is ignored."
https://t.co/ZA9X7LKwcA
The risk of progression to persistent AFib at 3 years is reduced by almost 7-fold in patients with paroxysmal AFib treated using catheter ablation compared with patients treated using anti-arrhythmic medical therapy. https://t.co/f8GntGewpp
ARREST-AF *Randomized Clinical Trial*
(Aggressive Risk factor REduction STudy for #AtrialFibrillation for #ablation)
♥️Lifestyle factor mgmnt ➡️
significant freedom from #Afib post ablation 61.3% vs 40%
HR 0.53 p=0.03
Congrats @drrpathak @PrashSanders & team!
#AHA24#EPeeps
ARREST-AF *Randomized Clinical Trial*
(Aggressive Risk factor REduction STudy for #AtrialFibrillation for #ablation)
♥️Lifestyle factor mgmnt ➡️
significant freedom from #Afib post ablation 61.3% vs 40%
HR 0.53 p=0.03
Congrats @drrpathak @PrashSanders & team!
#AHA24#EPeeps
Conduction system pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with heart failure and mildly reduced left ventricular ejection fraction: Results from International Collaborative LBBAP Study (I-CLAS) Group
https://t.co/iR5T6bqRLa